GlassScriptPhysician profile
Jonathan Adam Sherman
NPI 1871695122
$6,727.78
in general payments reported to CMS, 2019-2025
35 companies · $576 in 2025
The $576 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,118 · 2020: $943 · 2021: $372 · 2022: $575 · 2023: $225 · 2024: $920 · 2025: $576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,720.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,698.65 | 2019-2020 | |
| Boston Scientific Corporation | $913.71 | 2019-2021 | |
| Edwards Lifesciences Corporation | $472.09 | 2019-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Shockwave Medical, INC | $384.92 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $379.66 | 2019-2024 | |
| Penumbra, INC. | $313.33 | 2024-2025 | Indigo System |
| E.R. Squibb & Sons, L.L.C. | $273.03 | 2019-2025 | Eliquis, Camzyos |
| Amgen INC. | $248.33 | 2019-2025 | Repatha |
| Abiomed | $239.07 | 2019-2024 | Impella |
| Kestra Medical Technology Services, INC. | $222.96 | 2022 | |
| Medtronic, INC. | $191.61 | 2021-2025 | Onyx Frontier, Symplicity G3 |
| Philips North America LLC | $180.29 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $177.37 | 2024 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Cardioform Septal Occluder |
| Janssen Pharmaceuticals, INC | $163.87 | 2019-2024 | Xarelto |
| Pfizer INC. | $141.86 | 2019-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $136.90 | 2022 | |
| Sanofi-Aventis U.S. LLC | $100.53 | 2019-2024 | |
| Biotronik INC. | $82.02 | 2019-2021 | |
| Gilead Sciences, INC. | $43.46 | 2019 | |
| Heartflow, INC. | $36.94 | 2024 | |
| Abbott Laboratories | $31.69 | 2020-2022 | |
| Astellas Pharma US INC | $31.62 | 2019 | |
| Allergan, INC. | $30.81 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.28 | 2019-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $27.09 | 2021-2023 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $23.09 | 2019-2020 | |
| Baxter Healthcare | $21.66 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Cleerly, INC. | $21.49 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Kiniksa Pharmaceuticals, LTD. | $20.64 | 2023 | Arcalyst |
| Cvrx, INC. | $18.45 | 2024 | Barostim Neo System |
| Alnylam Pharmaceuticals INC. | $17.61 | 2024 | Onpattro |
| Biosense Webster, INC. | $14.84 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $13.72 | 2019 | |
| Lundbeck LLC | $13.37 | 2019 | |
| Akcea Therapeutics, INC. | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Sherman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.